- Adverse effects of combination immunotherapy in renal cancer, lung cancer, and melanoma +12022 | Faculty of Medicine in Hradec Králové
- Comments on the Clinical Development of Ipilimumab2013 | Publication without faculty affiliation
- Melanoma antigens are biomarkers for ipilimumab response2017 | Central Library of Charles University, Third Faculty of Medicine